臨床薬理の進歩 No.43
65/233

00000(表1 前頁より続く)0.023173 (57%)133 (43%)0.10236 (76%)75 (24%)0.296 (2%)214 (69%)16 (5%)75 (24%)0.2287 (28%)219 (72%)0.9493 (30%)217 (70%)0.8522 (7%)49 (16%)86 (28%)116 (37%)38 (12%)0.11242 (78%)69 (22%)349 ± 145153 (50%)153 (50%)474 ± 429153 (50%)153 (50%)0.690.910.180.370.67270 (88%)37 (12%)0.14266 (85%)24 (8%)21 (7%)0.31248 (80%)63 (20%)Adjuvant chemotherapyHistological subtypesLauren classificationIntestinalDiffuseWHO classificationPapillaryTubularMucinousPoorly cohesiveLymphatic invasionVenous invasionKi-67 indexSurgical approachOperative time (min, mean ± SD)<319 (median)≧319 (median)Blood loss volume (g, mean ± SD)<351 (median)≧351 (median)Blood transfusionResection marginPreoperative complicationsNone or Clavien-Dindo <ⅢaClavien-Dindo ≧ⅢaSD, standard deviation. *p = 0.0037、**p = 0.0044、***p = 0.0008AbsentPresent212 (59%)146 (41%)279 (77%)84 (23%)7 (2%)254 (70%)18 (5%)84 (23%)AbsentPresent106 (30%)251 (70%)AbsentPresent109 (30%)251 (70%)0-9%10-29%30-49%50-79%80-100%24 (7%)55 (15%)101 (28%)135 (37%)48 (13%)TranshiatalTransthoracic289 (80%)74 (20%)345 ± 140178 (50%)179 (50%)472 ± 418178 (50%)178 (50%)AbsentPresent313 (87%)45 (13%)R0R1R2317 (87%)24 (7%)22 (6%)285 (79%)78 (21%)23 (82%)5 (18%)16 (67%)8 (33%)26 (93%)2 (7%)17 (71%)7 (29%)1 (4%)16 (67%)24 (86%)2 (7%)2 (7%)7 (29%)12 (44%)15 (56%)7 (29%)17 (71%)8 (31%)18 (69%)8 (33%)16 (67%)1 (4%)2 (7%)8 (29%)11 (39%)6 (21%)1 (4%)4 (17%)7 (29%)8 (33%)4 (17%)25 (89%)3 (11%)337 ± 12213 (46%)15 (54%)548 ± 39211 (41%)16 (59%)22 (92%)2 (8%)305 ± 8012 (52%)11 (48%)359 ± 25714 (61%)9 (39%)20 (87%)3 (13%)23 (82%)5 (18%)23 (96%)28 (100%)1 (4%)18 (75%)6 (25%)19 (68%)9 (32%)51

元のページ  ../index.html#65

このブックを見る